Interleukin-1, anorexia, and dietary fatty acids

Area of Science:

• Biomedical Science
• Nutrition Science
• Immunology

Background:

• Interleukin-1 (IL-1) and other cytokines are implicated in pathological processes, including cachexia in cancer and chronic infections.
• Cachexia, characterized by reduced food intake and weight loss, is a significant complication in various diseases.

Purpose of the Study:

• To investigate the role of IL-1 in reducing food intake and its modulation by N-3 fatty acids.
• To explore the mechanisms by which N-3 fatty acids affect IL-1 production and its anorexic effects.

Main Methods:

• Administration of recombinant IL-1 beta or IL-1 alpha to experimental animals to assess effects on food intake and weight gain.
• Utilizing cyclooxygenase inhibitors to investigate the IL-1 anorexic pathway.
• Supplementing animal diets with N-3 fatty acids and analyzing cyclooxygenase and lipoxygenase metabolite production.
• Measuring IL-1 production in leukocytes from human subjects taking N-3 fatty acid supplements.

Main Results:

• IL-1 significantly reduced food intake and slowed weight gain in meal-fed rats.
• The anorexic effect of IL-1 was attenuated by cyclooxygenase inhibitors and N-3 fatty acid supplementation.
• N-3 fatty acids reduced IL-1 production in human leukocytes, potentially via the lipoxygenase pathway.

Conclusions:

• IL-1-induced anorexia involves cyclooxygenase metabolites, such as PGE2.
• N-3 fatty acids may alleviate anorexia by reducing both the sensitivity to IL-1 and IL-1 synthesis.
• N-3 fatty acid supplementation shows promise for managing anorexia in disease states.